Menu

• Ask a Health Expert about SUPERIOR VENA CAVAL OCCLUSION
• Post Your Side Effect related to SUPERIOR VENA CAVAL OCCLUSION
• SUPERIOR VENA CAVAL OCCLUSION and FDA Warnings
• SUPERIOR VENA CAVAL OCCLUSION in Patients Wiki
• Report SUPERIOR VENA CAVAL OCCLUSION in Drug Side Effect Survey

SUPERIOR VENA CAVAL OCCLUSION side effect

What is SUPERIOR VENA CAVAL OCCLUSION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Copaxone Side Effects Report #5634122-4
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on July 19, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: superior vena caval occlusion, syncope, thrombosis, . COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5626288-7
GEMZAR problem was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 62 years of age, weighting 202.0 lb, was diagnosed with ovarian cancer recurrent and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, superior vena caval occlusion, . GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Paraplatin Side Effects Report #5503785-6
Health Professional from FRANCE reported PARAPLATIN problem on Oct 29, 2007. Male patient, 57 years of age, was diagnosed with lung neoplasm malignant and was treated with PARAPLATIN. After drug was administered, patient experienced the following problems/side effects: pancytopenia, superior vena caval occlusion, . PARAPLATIN dosage: STARTED ON 17APR07,CUMULATIVE DOSE TO 2291 MG. During the same period patient was treated with TAXOL, GEMZAR, CISPLATIN, TAXOTERE, ALIMTA, PREVISCAN, DOLIPRANE. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5563261-1
TARCEVA problem was reported by a Physician from ROMANIA on Nov 26, 2007. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cyanosis, face oedema, superior vena caval occlusion, . TARCEVA dosage: 150 MG, QD, ORAL. During the same period patient was treated with CISPLATIN, PACLITAXEL. Patient died on 11/11/2007.


Lapatinib Side Effects Report #5347942-0
Physician from UNITED KINGDOM reported LAPATINIB problem on May 31, 2007. Female patient, 63 years of age, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspnoea, superior vena caval occlusion, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Lapatinib Side Effects Report #5355619-0
LAPATINIB problem was reported by a Physician from UNITED KINGDOM on June 08, 2007. Female patient, 63 years of age, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspnoea, superior vena caval occlusion, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.